Bank of America’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-24,992
| Closed | -$16K | – | 7627 |
|
|
2017
Q4 | $16K | Sell |
24,992
-28,483
| -53% | -$14.4K | ﹤0.01% | 6499 |
|
|
2017
Q3 | $17K | Sell |
53,475
-2,612
| -5% | -$916 | ﹤0.01% | 6354 |
|
|
2017
Q2 | $26K | Buy |
56,087
+10,211
| +22% | +$7.42K | ﹤0.01% | 6145 |
|
|
2017
Q1 | $55K | Buy |
45,876
+7,151
| +18% | +$8.94K | ﹤0.01% | 5892 |
|
|
2016
Q4 | $51K | Sell |
38,725
-2,085
| -5% | -$3.63K | ﹤0.01% | 5922 |
|
|
2016
Q3 | $85K | Buy |
40,810
+446
| +1% | +$882 | ﹤0.01% | 5506 |
|
|
2016
Q2 | $65K | Sell |
40,364
-15,730
| -28% | -$30.2K | ﹤0.01% | 5726 |
|
|
2016
Q1 | $54K | Buy |
56,094
+4,543
| +9% | +$4.43K | ﹤0.01% | 5759 |
|
|
2015
Q4 | $62K | Sell |
51,551
-328,246
| -86% | -$1.05M | ﹤0.01% | 5956 |
|
|
2015
Q3 | $2.82M | Sell |
379,797
-142,477
| -27% | -$1.09M | ﹤0.01% | 3446 |
|
|
2015
Q2 | $3.73M | Buy |
522,274
+156,186
| +43% | +$1.22M | ﹤0.01% | 2858 |
|
|
2015
Q1 | $3.15M | Buy |
366,088
+23,372
| +7% | +$209K | ﹤0.01% | 2851 |
|
|
2014
Q4 | $3.42M | Buy |
342,716
+36,291
| +12% | +$309K | ﹤0.01% | 2886 |
|
|
2014
Q3 | $3.03M | Buy |
306,425
+67,930
| +28% | +$1.01M | ﹤0.01% | 3005 |
|
|
2014
Q2 | $4.13M | Buy |
238,495
+36,980
| +18% | +$603K | ﹤0.01% | 2734 |
|
|
2014
Q1 | $3.57M | Buy |
201,515
+99,719
| +98% | +$1.93M | ﹤0.01% | 2699 |
|
|
2013
Q4 | $1.86M | Sell |
101,796
-14,952
| -13% | -$282K | ﹤0.01% | 3386 |
|
|
2013
Q3 | $3.13M | Buy |
116,748
+3,239
| +3% | +$69.4K | ﹤0.01% | 2820 |
|
|
2013
Q2 | $2.09M | Buy |
+113,509
| New | +$2M | ﹤0.01% | 3150 |
|
Bank of America's RPRX Position: Q1 2018 in Review
Bank of America sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 24,992 shares — an estimated $16K sold.
Bank of America first reported a position in RPRX in Q2 2013 and held it in 19 quarters. The position peaked at $4.13M in Q2 2014. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.
- Bank of America reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
- Bank of America sold 24,992 Repros Therapeutics Inc. shares in Q1 2018, an estimated $16K.
- Bank of America first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 19 quarters.
- Bank of America's Repros Therapeutics Inc. position peaked at $4.13M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.
Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.